Successful Treatment of Paraneoplastic Mesangioproliferative Glomerulonephritis in Mantle Cell Lymphoma Using Acalabrutinib and Rituximab

被引：0
|
作者：
Wadhera, Sarthak [1 ]
Swain, Rudra Narayan [1 ]
Saini, Shashikant [2 ]
Sekar, Arvind [3 ]
Sharma, Praveen [4 ]
Sethi, Jasmine [5 ]
Sachdeva, Man Updesh [4 ]
Malhotra, Pankaj [1 ]
机构：
[1] Postgrad Inst Med Educ & Res, Dept Clin Hematol & Med Oncol, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India
[3] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh, India
[4] Postgrad Inst Med Educ & Res, Dept Hematol, Chandigarh, India
[5] Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh, India
来源：
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION | 2024年
关键词：
Mantle cell lymphoma; Mesangioproliferative glomerulonephritis; Acalabrutinib;
D O I：
10.1007/s12288-024-01922-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Lymphomatous interstitial nephritis coexistent with paraneoplastic crescentic membranoproliferative glomerulonephritis in a case of mantle cell lymphoma
    Etta, Praveen Kumar
    Rao, M., V
    Reddy, Sujeet
    Gowrishankar, Swarnalata
    Agarwal, Neha
    INDIAN JOURNAL OF NEPHROLOGY, 2020, 30 (03) : 192 - 195
  • [22] Successful treatment of a rare variant of mesangioproliferative glomerulonephritis with IgM deposits with cyclosporin A
    Gurova, D., V
    Chebotareva, N., V
    Vinogradov, A. A.
    Stavrovskaya, E., V
    Lysenko, L., V
    TERAPEVTICHESKII ARKHIV, 2020, 92 (06) : 73 - 75
  • [23] Treatment of Synchronous Mantle Cell Lymphoma and Small Lymphocytic Lymphoma with Bendamustine and Rituximab
    Kourelis, Taxiarchis V.
    Kahl, Brad S.
    Benn, Peter
    Delach, Judith A.
    Bilgrami, Syed F.
    ACTA HAEMATOLOGICA, 2011, 126 (01) : 40 - 43
  • [24] Is rituximab retro in mantle cell lymphoma?
    Ryan, Christine E.
    Cohen, Jonathon B.
    BLOOD, 2024, 144 (03) : 241 - 243
  • [25] Successful intraperitoneal rituximab treatment in a patient with therapy-resistant malignant ascites due to mantle cell lymphoma
    Charlott Mörth
    Hans Hagberg
    Annals of Hematology, 2015, 94 : 1757 - 1758
  • [26] Successful intraperitoneal rituximab treatment in a patient with therapy-resistant malignant ascites due to mantle cell lymphoma
    Morth, Charlott
    Hagberg, Hans
    ANNALS OF HEMATOLOGY, 2015, 94 (10) : 1757 - 1758
  • [27] Chronic paraneoplastic cutaneous syndrome preceding an indolent variant of mantle cell lymphoma: Favorable response to rituximab
    Nemets, A
    Ronen, M
    Lugassy, G
    ACTA HAEMATOLOGICA, 2006, 115 (1-2) : 113 - 116
  • [28] Cladribine plus rituximab for the initial treatment of mantle cell lymphoma.
    Pindyck, T.
    Spurgeon, S. E.
    Okada, C. Y.
    Epner, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma - a Phase II Clinical Trial
    Jain, Preetesh
    Young, Chi
    Nastoupil, Loretta J.
    Westin, Jason
    Hill, Holly A.
    Nair, Ranjit
    Iyer, Swami P.
    Fetooh, Ahmed
    Lee, Hun Ju
    Ahmed, Sairah
    Kanagal-Shamanna, Rashmi
    Jelloul, Fatima Z.
    Castillo, Luis Enrique Malpica
    Liu, Yang
    Li, Yijing
    Vargas, Jovanny
    Feng, Lei
    Badillo, Maria
    Thirumurthi, Selvi
    Xu, Guofan
    Deswal, Anita
    Iliescu, Cezar
    Nguyen, Vinh Quang
    Tang, Guilin
    Patel, Keyur P.
    Vega, Francisco
    Medeiros, L. Jeffrey
    Wang, Michael L.
    Flowers, Christopher R.
    BLOOD, 2023, 142
  • [30] Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma
    Ruan, Jia
    Martin, Peter
    Shah, Bijal
    Schuster, Stephen J.
    Smith, Sonali M.
    Furman, Richard R.
    Christos, Paul
    Rodriguez, Amelyn
    Svoboda, Jakub
    Lewis, Jessica
    Katz, Orel
    Coleman, Morton
    Leonard, John P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19): : 1835 - 1844
12345